Wolverine Trading’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3M | Sell |
15,900
-7,700
| -33% | -$1.37M | ﹤0.01% | 1818 |
|
|
2025
Q2 | $4.2M | Sell |
23,600
-13,300
| -36% | -$2.31M | ﹤0.01% | 1162 |
|
|
2025
Q1 | $6.17M | Buy |
36,900
+25,600
| +227% | +$4.21M | 0.01% | 878 |
|
|
2024
Q4 | $1.71M | Buy |
11,300
+1,100
| +11% | +$171K | ﹤0.01% | 2106 |
|
|
2024
Q3 | $1.58M | Buy |
10,200
+1,500
| +17% | +$224K | ﹤0.01% | 1902 |
|
|
2024
Q2 | $1.19M | Sell |
8,700
-1,900
| -18% | -$260K | ﹤0.01% | 2035 |
|
|
2024
Q1 | $1.41M | Sell |
10,600
-1,800
| -15% | -$234K | ﹤0.01% | 1881 |
|
|
2023
Q4 | $1.71M | Buy |
12,400
+4,200
| +51% | +$552K | ﹤0.01% | 1826 |
|
|
2023
Q3 | $999K | Buy |
8,200
+2,100
| +34% | +$280K | ﹤0.01% | 2111 |
|
|
2023
Q2 | $861K | Sell |
6,100
-2,400
| -28% | -$331K | ﹤0.01% | 2123 |
|
|
2023
Q1 | $1.18M | Buy |
8,500
+2,300
| +37% | +$329K | ﹤0.01% | 1756 |
|
|
2022
Q4 | $970K | Buy |
6,200
+2,700
| +77% | +$388K | ﹤0.01% | 1865 |
|
|
2022
Q3 | $436K | Sell |
3,500
-1,800
| -34% | -$237K | ﹤0.01% | 2759 |
|
|
2022
Q2 | $729K | Sell |
5,300
-8,800
| -62% | -$1.2M | ﹤0.01% | 2190 |
|
|
2022
Q1 | $1.96M | Sell |
14,100
-3,300
| -19% | -$460K | ﹤0.01% | 1788 |
|
|
2021
Q4 | $2.98M | Sell |
17,400
-37,600
| -68% | -$5.72M | ﹤0.01% | 1531 |
|
|
2021
Q3 | $8.12M | Buy |
55,000
+5,100
| +10% | +$746K | 0.01% | 949 |
|
|
2021
Q2 | $6.64M | Buy |
49,900
+20,400
| +69% | +$2.67M | 0.01% | 922 |
|
|
2021
Q1 | $3.79M | Buy |
29,500
+16,700
| +130% | +$2.06M | 0.01% | 1349 |
|
|
2020
Q4 | $1.51M | Buy |
+12,800
| New | +$1.56M | ﹤0.01% | 1958 |
|
|
2020
Q3 | – | Sell |
-18,600
| Closed | -$2.05M | – | 4625 |
|
|
2020
Q2 | $2.05M | Sell |
18,600
-3,900
| -17% | -$414K | 0.01% | 1402 |
|
|
2020
Q1 | $1.87M | Buy |
22,500
+2,900
| +15% | +$300K | 0.01% | 1405 |
|
|
2019
Q4 | $2.08M | Sell |
19,600
-2,400
| -11% | -$250K | 0.01% | 1802 |
|
|
2019
Q3 | $2.32M | Buy |
+22,000
| New | +$2.26M | 0.01% | 1337 |
|
|
2019
Q2 | – | Sell |
-39,500
| Closed | -$3.55M | – | 4536 |
|
|
2019
Q1 | $3.55M | Buy |
39,500
+14,100
| +56% | +$1.22M | 0.01% | 1099 |
|
|
2018
Q4 | $2.08M | Sell |
25,400
-13,400
| -35% | -$1.26M | 0.01% | 1374 |
|
|
2018
Q3 | $4.19M | Buy |
38,800
+20,600
| +113% | +$2.26M | 0.01% | 1097 |
|
|
2018
Q2 | $1.82M | Hold |
18,200
| – | – | ﹤0.01% | 1677 |
|
|
2018
Q1 | $1.82M | Sell |
18,200
-400
| -2% | -$41K | ﹤0.01% | 1677 |
|
|
2017
Q4 | $1.83M | Buy |
18,600
+4,200
| +29% | +$398K | 0.01% | 1627 |
|
|
2017
Q3 | $1.35M | Buy |
+14,400
| New | +$1.53M | 0.01% | 1635 |
|
|
2017
Q2 | – | Sell |
-3,000
| Closed | -$295K | – | 4382 |
|
|
2017
Q1 | $295K | Buy |
+3,000
| New | +$286K | ﹤0.01% | 3046 |
|
|
2016
Q4 | – | Sell |
-29,400
| Closed | -$2.46M | – | 4541 |
|
|
2016
Q3 | $2.46M | Buy |
29,400
+9,500
| +48% | +$798K | 0.01% | 1186 |
|
|
2016
Q2 | $1.59M | Buy |
+19,900
| New | +$1.52M | 0.01% | 1261 |
|
Other funds holding DGX
Wolverine Trading's DGX Position: Q3 2025 in Review
Wolverine Trading increased its Quest Diagnostics (DGX) stake by 230% in Q3 2025, buying an estimated $1.18M and bringing the position to 9,568 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.
Wolverine Trading first reported a position in DGX in Q1 2017 and has held it in 17 quarters since. The position peaked at $4.82M in Q2 2021. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.
- Wolverine Trading held 9,568 shares of Quest Diagnostics worth $1.81M as of Q3 2025.
- Wolverine Trading bought 6,672 Quest Diagnostics shares in Q3 2025, an estimated $1.18M.
- Quest Diagnostics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2270 holding.
- Wolverine Trading first reported a position in Quest Diagnostics in Q1 2017 and has held it in 17 quarters since.
- Wolverine Trading's Quest Diagnostics position peaked at $4.82M in Q2 2021.
- 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.